Search

everythinglearnresearchcommunity

for

Search:↓

Telogen effluvium is the most common hair loss in women, often linked to low iron, while tight hairstyles and headscarves increase traction alopecia risk.

Trichoscopy is a quick and reliable way to diagnose hair loss in women.

Certain growth factors affect hair loss in women and could be targeted for treatment.

Hair loss in women can be due to abnormal hair growth cycles or damaged hair follicles, with the most common type being androgenetic alopecia; treatment varies by cause, and the psychological impact is significant.

Almost 40% of Greek women with acne show signs of androgen-related disorders, with adult women more likely affected.

Alopecia in women can signal broader health issues and requires a thorough diagnosis to tailor treatments.

Androgenetic alopecia with telogen effluvium is the most common hair loss in women with hirsutism.

Minoxidil helps increase hair growth and density in people with hair loss, with higher concentrations giving better results.

Hair loss in women can be treated with hormone therapy.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

Finasteride improves acne and hair loss in women with normal testosterone.

The condition called 'acute diffuse and total alopecia of the female scalp' is actually a known condition named alopecia areata incognita.

A postmenopausal woman's hair loss and excess hair growth improved after surgery for ovarian hyperthecosis.

Low iron levels are linked to hair loss in women.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Routine thyroid tests for diffuse alopecia in women may not be necessary, but checking for iron deficiency anemia could be useful.

Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.

Low iron levels may be linked to some types of hair loss in women.

AI can help track and improve hair loss treatment outcomes.

An AI photographic device effectively tracked hair growth improvements in women treated for hair loss.

Having enough iron improves the effectiveness of a specific hair loss treatment in women.

Hormonal imbalances, including high prolactin and thyroid issues, contribute to hair growth problems in women.

Taking cyproterone acetate and ethinyl oestradiol for hair loss can lower vitamin B12 levels in women.

Post-COVID-19 hair loss is different from androgenetic alopecia and can be identified by lower copper and higher selenium levels.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Female hair loss can occur without androgens.

Regular use of sunscreen may be linked to frontal fibrosing alopecia.

Most Spanish Caucasian women have a widow's peak, and their hormone levels suggest they process certain hormones faster.

Frequent use of hair straighteners can cause hair loss similar to scarring alopecia in young Turkish women.